Understanding the Epilepsy in POLG Related Disease
Open Access
- 24 August 2017
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 18 (9) , 1845
Abstract
Epilepsy is common in polymerase gamma (POLG) related disease and is associated with high morbidity and mortality. Epileptiform discharges typically affect the occipital regions initially and focal seizures, commonly evolving to bilateral convulsive seizures which are the most common seizure types in both adults and children. Our work has shown that mtDNA depletion—i.e., the quantitative loss of mtDNA—in neurones is the earliest and most important factor of the subsequent development of cellular dysfunction. Loss of mtDNA leads to loss of mitochondrial respiratory chain (MRC) components that, in turn, progressively disables energy metabolism. This critically balanced neuronal energy metabolism leads to both a chronic and continuous attrition (i.e., neurodegeneration) and it leaves the neurone unable to cope with increased demand that can trigger a potentially catastrophic cycle that results in acute focal necrosis. We believe that it is the onset of epilepsy that triggers the cascade of damage. These events can be identified in the stepwise evolution that characterizes the clinical, Electroencephalography (EEG), neuro-imaging, and neuropathology findings. Early recognition with prompt and aggressive seizure management is vital and may play a role in modifying the epileptogenic process and improving survival.Keywords
Funding Information
- Helse Vest (911944, 911903, 911988)
- Norges Forskningsråd (240369/F20)
This publication has 38 references indexed in Scilit:
- Mitochondrial diseases and epilepsyEpilepsia, 2012
- Mitochondrial disease and epilepsyDevelopmental Medicine & Child Neurology, 2012
- Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromesBrain, 2010
- Status epilepticus in children with Alpers’ disease caused byPOLG1mutations: EEG and MRI featuresEpilepsia, 2009
- DNA polymerase gamma and mitochondrial disease: Understanding the consequence of POLG mutationsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2009
- Ketamine successfully terminates malignant status epilepticusEpilepsy Research, 2008
- Partial inhibition of complex I activity increases Ca2+‐independent glutamate release rates from depolarized synaptosomesJournal of Neurochemistry, 2008
- Molecular diagnosis of Alpers syndromeJournal of Hepatology, 2006
- Phenotypic spectrum associated with mutations of the mitochondrial polymerase geneBrain, 2006
- Treatment for mitochondrial myopathy2003